Experimental depression drug trial halted early
NCT ID NCT04249596
First seen Jan 23, 2026 · Last updated May 02, 2026 · Updated 15 times
Summary
This study tested the drug tianeptine in 38 adults with major depression that did not improve after at least two standard treatments. Participants took tianeptine for 8 weeks, and researchers measured changes in depression symptoms using a standard questionnaire. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mood and Anxiety Disorders Program at the Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
New York State Psychiatric Institute
New York, New York, 10032, United States
-
Stanford Depression Research Clinic at Stanford University School of Medicine
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.